Literature DB >> 11172704

Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity.

W A Banks1.   

Abstract

Leptin has emerged as a major regulator of adiposity. Leptin is released into the blood from fat cells and circulates to the brain where it crosses the blood-brain barrier (BBB) to act at receptors within the central nervous system to affect appetite, thermogenesis, and a number of other actions. In humans and in many rodent models, resistance to leptin appears to be a chief cause of obesity. Determining the cause of leptin resistance is fundamental to developing strategies for the use of leptin in obesity. The literature characterizing the transport of leptin across the BBB is reviewed. This literature strongly suggests that the cause of leptin resistance is due a decreased transport of leptin across the BBB in obese humans and rodents. The main cause of this resistance appears to be an impairment in the activity of the transporter rather than just simply saturation at higher doses. Strategies to overcome impaired BBB transport are reviewed, including the use of allosteric regulators and the delivery of material by the intrathecal route.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172704     DOI: 10.2174/1381612013398310

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  33 in total

Review 1.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

2.  Blood-borne metabolic factors in obesity exacerbate injury-induced gliosis.

Authors:  Hung Hsuchou; Abba J Kastin; Weihong Pan
Journal:  J Mol Neurosci       Date:  2012-03-04       Impact factor: 3.444

Review 3.  Control of energy homeostasis by amylin.

Authors:  Thomas A Lutz
Journal:  Cell Mol Life Sci       Date:  2011-12-23       Impact factor: 9.261

Review 4.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 5.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

6.  Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2008-05-28       Impact factor: 3.046

7.  Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.

Authors:  Susan A Farr; Michelle A Erickson; Michael L Niehoff; William A Banks; John E Morley
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.

Authors:  Egberto Gaspar de Moura; Isabela Teixeira Bonomo; José Firmino Nogueira-Neto; Elaine de Oliveira; Isis Hara Trevenzoli; Adelina Martha Reis; Magna Cottini Fonseca Passos; Patricia Cristina Lisboa
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

Review 9.  mTOR and regulation of energy homeostasis in humans.

Authors:  Marwan Mannaa; Stephanie Krämer; Michael Boschmann; Maik Gollasch
Journal:  J Mol Med (Berl)       Date:  2013-06-12       Impact factor: 4.599

10.  Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice.

Authors:  Anantha S Metlakunta; Maitrayee Sahu; Abhiram Sahu
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.